Archival samples represent a significant potential for genetic studies, particularly in severe diseases with risk of lethal outcome, such as in cancer. In this pilot study, we aimed to evaluate the usability of archival bone marrow smears and biopsies for DNA extraction and purification, whole genome amplification (WGA), multiple marker analysis including 10 short tandem repeats, and finally a comprehensive genotyping of 33,683 single nucleotide polymorphisms (SNPs) with multiplexed targeted next-generation sequencing. A total of 73 samples from 21 bone marrow smears and 13 bone marrow biopsies from 18 Danish and Norwegian childhood acute lymphoblastic leukemia patients were included and compared with corresponding blood samples. Samples were grouped according to the age of sample and whether WGA was performed or not. We found that measurements of DNA concentration after DNA extraction was dependent on detection method and that spectrophotometry overestimated DNA amount compared with fluorometry. In the short tandem repeat analysis, detection rate dropped slightly with longer fragments. After WGA, this drop was more pronounced. Samples stored for 0 to 3 years showed better results compared with samples stored for 4 to 10 years. Acceptable call rates for SNPs were detected for 7 of 42 archival samples. In conclusion, archival bone marrow samples are suitable for DNA extraction and multiple marker analysis, but WGA was less successful, especially when longer fragments were analyzed. Multiple SNP analysis seems feasible, but the method has to be further optimized.
A rchival samples such as biopsy specimen, cytologic smears, and hematological smears have been used in studies of genetic biomarkers for decades, not least within cancer research. [1] [2] [3] [4] [5] [6] [7] [8] However, poor DNA yield and structural changes such as degradation and mutations may influence results in both DNA sequencing and comprehensive marker analysis. Known factors contributing to possible poor DNA quality are sample age, storage, fixation, and staining. [9] [10] [11] Single nucleotide polymorphisms (SNPs) and short tandem repeats (STRs, microsatellites) are known biological markers, and marker-profiling has become an important part of modern diagnostic tools in cancer. [12] [13] [14] Retrospective studies focusing on marker arrays basically depend on highquality DNA stored in biobanks. Unfortunately, as research ideas sometimes are recognized a long time after the patient has finished treatment, often no systematic biobanking of samples would have been conducted. An alternative approach is to use samples already stored as part of the hospitals routine. For leukemia patients, bone marrow (BM) smears and biopsies are taken at diagnosis and during treatment and stored for many years. Surplus samples often exist, and in situations when a potential study participant has died, archival material may represent the only possible way to get DNA from that individual.
Studies so far including BM samples as DNA source in hematological malignancies explore only a few biological markers 4, 7, [15] [16] [17] and to the best of our knowledge, no studies have thoroughly investigated whether DNA from BM samples is suitable for multiple STR and SNP analysis. As poor DNA yield from archival samples may be an obstacle for multiple marker sequencing, whole genome amplification (WGA) possibly represents a solution to this problem. 7 We were interested in evaluating whether DNA extracted from BM smears and biopsies taken from children treated for acute lymphoblastic leukemia (ALL) were suitable for multiple marker analysis. We therefore conducted a pilot study where multiple markers from BM samples are compared with corresponding blood samples. We also evaluated whether WGA was feasible or not and the possible impact of storage time on sample quality. Furthermore, we explored 2 different measure methods of DNA concentration.
MATERIALS AND METHODS

Patients
Eighteen randomly chosen Norwegian (n = 11) and Danish (n = 7) childhood ALL patients with a total of 18 blood samples, 21 BM smears (1-2 smears per patient), and 13 BM biopsies were included in the study. All patients, aged 3 to 16 years at diagnosis, were diagnosed with ALL between 2001 and 2011 and followed antileukemic treatment according to NOPHO ALL 2000 or 2008 protocols. 18, 19 
Sample Selection
From the 18 included patients, a total of 21 surplus Giemsa-stained archival BM smears taken at diagnosis or in remission (Figs. 1A, B) were included. DNA was extracted and isolated as described below. From these 21 DNA samples, a total of 51 aliquots were prepared for marker analysis. After DNA extraction of the 13 BM biopsies was carried out, 22 aliquots were taken for marker analysis, giving a total of 73 archival samples included in our study. All preparations of the archival samples were performed during 2011. Smears and biopsies were divided in 2 major groups, 0 to 3 years old and 4 to 10 years old and were further divided in groups according to WGA, resulting in 7 subgroups as shown in Figure 2 . BM biopsies were taken at time of diagnosis from crista of the pelvic bone and fixed in 4% formalin (with phosphate buffer) for about 12 to 24 hours followed by decalcification in EDTA buffer and paraffin embedding (FFPE procedure; Fig. 1C ). All biopsies had been stored at room temperature for 0 to 9 years before DNA extraction. Blood was sampled during or after treatment (all taken during remission) between 2002 and 2011. DNA from whole blood was extracted and purified either by standard sodium chloride and ethanol precipitation or by use of QIAamp DNA Mini kit (Qiagen, GmbH, Germany) according to the manufacturer's instructions. Blood samples had been stored frozen for 0 to 9 years before marker analysis. WGA was not performed on the blood samples. DNA from blood samples was used as reference in our analysis.
DNA Extraction From BM Smears
The BM smears were observed macroscopically and microscopically to visually ensure a required minimum of cell content on the smear (Figs. 1A, B ). Among the 21 included smears, 12 had cover slides (fixed by use of Histokit), which were separated from the glass slide by immersion in xylene for 2 to 4 days followed by 3 consecutive 95% ethanol baths and were air dried for 2 to 4 days. Similar procedure has also been used by others. 20 phosphate-buffered saline (0.5 mL) was pipetted onto the glass slide and cells were carefully scraped off the slide surface with a scalpel into a microcentrifuge tube. DNA was extracted using QIAamp DNA Micro kit (Qiagen) according to the manufacturer's instructions and stored at À 201C. From these 21 DNA samples, 51 aliquots were taken for further analysis and grouped according to Figure 2 . REPLI-g FFPE kit (Qiagen) was chosen for WGA as it is designed particularly for fragmented DNA. Amplifications were according to the manufacturer's instructions.
DNA Extraction From BM Biopsies
Because of the hospital's archival routines, we were only allowed to take small parts of the biopsies (Fig. 1C ). Standard microtome technique was used for preparation of new sections of FFPE tissue with thickness of 10 mm. Five slices were included for each sample, which was comparable with other studies. 7 DNA processing was carried out with 2 different methods: (i) for marker analysis without WGA, DNA was extracted using QIAamp FFPE Tissue kit (Qiagen) according to the manufacturer's instruction, and (ii) for marker analysis including WGA, the REPLI-g FFPE kit (Qiagen) was used, which included DNA extraction, ligation, and amplification in the same procedure.
Quantity and Quality Measurements
Because of the expected poor quality and yield of extracted DNA from the archival material, quality and quantity assessment was considered a crucial step. For DNA concentration measurements, we used both spectrophotometry (SP) (NanoDrop ND 1000 Spectrophotometer; NanoDrop Technologies Inc., Wilmington, DE) and fluorometry (FM) (dsDNA BR assay; Qubit, Invitrogen, Carlsbad, CA). Gel electrophoresis was used to estimate fragment lengths of both amplified and nonamplified material.
STR Marker Analysis
For a subset (n = 11) of our patients, STR marker analyses were performed and included a total of 31 archival samples (groups 2 to 7). The AmpFl STR Profiler kit (Applied Biosystems, Foster, CA), a fluorescencebased PCR technique used for DNA "fingerprint" identification, was used. Amplifications were carried out according to the manufacturer's recommendation and analyzed on an ABI3730 capillary electrophoresis machine. The 10 STR loci had lengths varying from 107/ 113 bp (Amelogenin, sex marker) to 281/317 bp for the CSF1PO marker. Marker profiles of the archival material were compared with the corresponding marker profiles from blood samples. Detection rate of STRs was defined as the total number of detected STRs from the particular archival samples for all included patients in that group divided with the total number of STRs detected by blood samples for the group. This measure takes into account that some patients were either homozygous or heterozygous for the respective marker.
Library Preparation and SNP Sequencing
As a part of an ongoing childhood ALL project in our research group, we used a newly developed cost-effective high-throughput capture assay including analysis of 33,683 SNPs within 2254 candidate genes of relevance for childhood ALL. 21 A total of 59 extracted DNA samples (with or without WGA) were further processed for library preparation and SNP sequencing, including 17 samples derived from blood, 34 samples from smears, and 8 samples from biopsies (groups 1 to 4 and 6; Fig. 2 ). Library preparation was done according to SureSelectXT Target Enrichment System for Illumina Paired-End Multiplexed Sequencing, version 1.0, November 2010 (modified for single-end sequencing; Agilent Technologies, Santa Clara, CA) as earlier described by Wesolowska et al. 21 The library was sequenced using Illumina HiSeq 2000 (Illumina Int., San Diego, CA). The sequencing reads for each sample were mapped to the reference human genome build 37 (GRCh37) using Burrow-Wheelers Aligner. 22 The alignment was refined by means of alignment score, base quality score recalibration, and around indel realignment using Genome Analysis Toolkit, 23 filtered using the vcfutils.pl script from SAMtools package to remove any bias attributable to base quality score, strand, or position along the read. For the final analysis, SNP call rates were calculated, and archival SNP profiles were compared with corresponding blood SNP profiles for concordance calculations.
Statistics
In addition to the bioinformatic tools mentioned above, paired-sample t test was used in comparison of mean between SP and FM. When comparing paired samples, only dataset with both measures available were included. Comparison of different detection rates in STR analysis was done using the w 2 test.
Ethics
The study was approved by research ethics committees in Denmark (H-D-2007-0100) and Norway (RECnr 2010/803). Written informed consent was collected from all patients, and the study was performed in accordance with the Declaration of Helsinki. Table 1 shows concentrations and amounts of DNA from the included 21 smears before WGA, measured by both SP and FM. The DNA concentration differed significantly between the 2 methods with mean concentrations of 68.0 ± 43.5 and 29.0 ± 20.0 ng/mL for SP and FM, respectively (P < 0.001). Values obtained with FM showed in average 43% of the values obtained with SP measurements (all samples except 1 were in the range of 32% to 59%). AS DNA was dissolved in 50 mL solvent, the mean DNA amount per smear was 3.49 ± 2.19 and 1.50 ± 1.02 mg with SP and FM, respectively. Mean DNA concentrations for BM biopsies were 103.8 ± 73.1 and 5.1 ± 3.7 ng/mL measured by SP and FM, respectively (P = 0.003). Mean DNA concentration after WGA was 2441 ± 160 measured by SP (n = 28) and 610 ± 179 ng/ mL measured by FM (n = 8) (see Supplementary Table, Supplemental Digital Content 1, http://links.lww.com/ PDM/A48). After purification of the samples, the mean concentration significantly dropped to 232 ± 147 ng/mL, for SP only (n = 20, P < 0.001). DNA isolated from both biopsies and smears was separated by agarose gel electrophoresis and showed varying degree of a faint "smear" and no clear bands, illustrating the fragmented nature of archival DNA samples. Moreover, long fragments (23 kbp) were visible.
RESULTS
Quantity and Quality Estimations
STR Marker Analysis
For the STR marker analysis, all 10 markers were identified for all blood samples. As a quality check, the sex marker (amelogenin) matched 100% with sex according to the patient files. In addition, these controls were also used to match markers analyzed from archival samples representing the same individuals. Table 2 shows the results of the STR marker analysis. The detection rate of markers for smears was 93% compared with 88% for biopsies. Analysis of WGA products for smears and biopsies showed significantly lower detection rates of 28% (P < 0.001) and 63.4% (P < 0.001), respectively (for raw data, see Supplementary Table, Supplemental Digital Content 2, http://links.lww.com/PDM/A49). When samples were grouped according to time after collection, detection rate of markers was significantly higher for samples stored for 0 to 3 years than for the older samples stored for 4 to 10 years. For smears, detection rates were 100% and 87% (P = 0.001), for 0 to 3 years versus 4 to 10 years, respectively, and for biopsies, detection rates were 97% and 81% (P = 0.003), for 0 to 3 years versus 4 to 10 years, respectively. Comparison of fragment lengths of different sample groups is illustrated in Figure 3 . Each line (group) represents different sets of material (ie, blood/ smear/WGA from smear/biopsy/WGA from biopsy). The figure shows that the detection rate for the BM samples decreases with increasing marker length, and this tendency is most striking for the WGA products. For WGA products from smears, no amplification from the largest amplicon size was detected (CSF1P0, 281-317 bp; D7S820, 258-294 bp).
SNP Sequencing
Of the initial 59 samples taken for SNP genotyping, 2 samples failed during library preparation (1 blood sample and 1 smear), leaving 57 samples that entered sequencing. SNP calls and call rates were evaluated at sequencing read depths of 4 Â and 10 Â . After exclusion of samples with too many duplicates and too low raw reads, 13 archival samples (all derived from smears) had SNP calls above 10,000 at 4Â read depth. Of these, 7 archival samples had SNP calls above 17,000 (ie, 50% of the approximately 34,000 intended SNPs; Table 3 ). Concordance varied from 87% to 100% for total reference SNP sites and, except for 2 samples (ID1 and ID5), from 73% to 99% for total variant SNP sites. For ID1 and ID5, we have no reasonable explanation for the low concordance. For the 7 samples included in Table 3 , the percentage of the read outs from the total number of bases in the capture target (n = 3,796,632) ranged from 44% to 90% at 4Â and from 21% to 77% at 10Â reading depth. The 7 samples belonged to group 1 (n = 2; 0-to 3-y old, +WGA), group 2 (n = 2; 0-to 3-y old, À WGA), and group 3 (n = 3; 4-to 10-y old, +WGA). The 2 smears with highest concordance (96% to 100%) belonged to groups 1 and 2. None of the 8 samples derived from biopsies had SNP calls above 10,000.
DISCUSSION
Archival biological samples, not initially intended for research, represent a great potential in molecular biology studies. In this study, we evaluated whether archival BM samples were suitable for DNA extraction, WGA and multiple STR and SNP analysis. We observed significant and reproducible differences between SP and FM for DNA concentration measurements, which can be of crucial importance for further downstream analysis. Higher concentrations of nucleotides derived from FFPE samples by use of SP compared with FM have also been found by others. 26 Overestimation of DNA in ultraviolet absorbance (SP) analysis might be caused by contamination with other molecules including RNA or free nucleic acids. 27 These factors might contribute to an Included were10 STR markers analyzed in 5 to 11 patients for the different samples. Maximum number of alleles was counted for all blood samples for all patients. Some alleles were homozygous and others were heterozygous, resulting in 15 to 18 different alleles per blood sample.
*Detection rate in percentage is the ratio between the number of alleles detected and maximum number of alleles (times 100). wFor patient numbers 1-6 ( Supplementary Table, Supplemental Digital Content 2, http://links.lww.com/PDM/A49), there was a systematic mismatch of unknown origin between biopsy samples and blood for the STR markers in which the PCR product was 1 to 4 bp shorter for most of the alleles. We interpret data so that there was no truly significant mismatch between biopsies and corresponding blood samples.
PCR indicates polymerase chain reaction; STR, short tandem repeats; WGA, whole genome amplification. overestimation of the DNA concentration leading to poor end results in downstream analysis. In a study by Haque et al, 28 quantification of DNA by SP is compared with 2 FM methods and they found that SP was the most concordant and precise DNA quantification method. The most reliable DNA estimation tool in our setting seems unclear. To avoid a possible overestimation of DNA concentration, we used FM for our STR and SNP analysis.
For multiple marker analysis in general, a certain minimum amount of DNA will be required. As availability of patient DNA may be poor and as we observed that DNA yield varied a lot between our archival samples, we introduced WGA as an attempt to increase the amount of DNA for further downstream analysis. We found high yield of DNA concentration after WGA (Supplemental Digital Content 1, http://links.lww.com/ PDM/A48), and we recognized long fragments of WGA products by gel electrophoresis. However, WGA samples were less successful in multiple SNP and STR marker analysis.
In the STR analysis, we were able to detect most markers with a detection rate of about 90% for the archival material. This is in accordance with other studies on BM smears 17, 29 and biopsies. 30, 31 Our findings that the younger archival materials showed best results illustrate that DNA quality from processed samples (eg, FFPE samples, stained and fixed smears) might decline during storage. In our evaluation of fragment lengths using STR markers, we found that DNA from smears and biopsies were able to amplify up to about 250 bp with high but not 100% success rate. Others have also had difficulties with amplification of DNA fragment lengths above 200 to 300 bp from FFPE samples, both in BM 30 and other tissues. 16, 32 For WGA products, amplification drops dramatically with increasing fragment length ( Fig. 3) probably because of fragmentation and cross-linking in archival samples. 11 WGA efficiency depends partly on DNA fragment length, and according to the manufacturer, it is recommended that DNA substrate should contain some fragments of at least of 500 bp.
Concerning SNP analysis, only 7 of the 34 smearderived and none of the biopsy-derived samples had call rates above 50%. As only a few samples successfully completed SNP analysis, general conclusions cannot be drawn. SNP profiling with multiplexed targeted sequencing is a complex laboratory procedure and errors can be generated at many different steps, not least with poor quality DNA. Interestingly, however, we did succeed with some samples illustrating that multiple SNP profiling based on DNA from smears might be feasible with some adjustments of the laboratory setup. Furthermore, we managed to successfully perform SNP profiling for 2 samples without WGA, thus illustrating that WGA might not be necessary and can potentially introduce bias or noise in our analysis. However, we also succeeded with 5 WGA samples; therefore, we cannot conclude on whether to recommend WGA or not. Without WGA, it might be a problem with too small DNA amount from a single smear. A solution might be to use 2 or 3 smears per sample to increase DNA yield, or using other microarray-based methods without target selection and multiplexing that require lesser DNA starting amount.
In conclusion, most archival BM samples are suitable for DNA extraction and multiple marker analysis. It was further shown that, although increasing the total amount of DNA, WGA reduces analysis quality. DNA quality depends on age, and STR marker analysis based on archival samples of relatively young age without WGA showed the best results. Complex SNP analysis including thousands of polymorphisms in a single analysis might be feasible, but the method has to be further optimized.
